Skip to main content

Table 6 Multivariate analysis of OS on pretreatment quality of life of QLQ-C30 among 501 patients with nasopharyngeal carcinoma

From: Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT

 

HR

95%CI

P

Age

1.329

0.516–3.427

0.556

Gender

0.493

0.136–1.795

0.284

Marriage

1.524

0.226–10.298

0.665

Education

1.145

0.763–1.720

0.513

Smoking history

1.246

0.483–3.216

0.650

Alcohol history

0.268

0.034–2.125

0.213

T stage

2.353

0.539–10.275

0.255

N stage

1.675

0.686–4.090

0.257

Pre-treatment EBV DNA

0.816

0.342–1.946

0.646

Post-treatment EBV DNA

11.202

1.473–85.184

0.020

Pain

1.028

0.996–1.061

0.091

Swallowing

1.014

0.978–1.050

0.458

  1. Abbreviations: OS Overall sruvival, HR Harsard ratio
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us